Panther Biotech (PBYA) Makes Pre-IND Meeting Request with FDA Regarding TRF-DOX Development
Tweet Send to a Friend
Panther Biotechnology, Inc. (OTC: PBYA) announced that a request for a Pre-IND (Investigational New Drug) meeting with the Division of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
